News & Perspective

Dec 28, 2012

Dec 28, 2012

Flu markers keep climbing in US and Europe

Editor's Note: The fourth paragraph was revised on Jan 2 to clarify the current situation regarding H3N2 dominance.

(CIDRAP News) – US influenza activity continued its ascent last week, judging from the high volumes of patients seeking care for the disease at doctors' offices, while flu indicators in Europe showed a clear spike, according to the latest surveillance reports.

Dec 21, 2012

Dec 21, 2012

Flu pace picks up in US, Canada, parts of Europe

(CIDRAP News) – Flu activity in the Northern Hemisphere continued to climb last week, led by a vigorous pace of infections in the United States and Canada in the lead-up to the Christmas holiday season, the World Health Organization (WHO) said today.

Nov 16, 2012

Nov 16, 2012

Europe reports continued rise in antibiotic resistance

(CIDRAP News) – European health officials are seeing a continued rise in multiple antibiotic resistance in Klebsiella pneumoniae and Escherichia coli, a pattern they say is likely fueled by misuse of the drugs, according to new data.

Nov 15, 2012

Nov 15, 2012

FDA panel endorses H5N1 vaccine with adjuvant

(CIDRAP News) – A government advisory committee yesterday endorsed the safety and immunogenicity of an adjuvant-containing H5N1 influenza vaccine proposed for inclusion in the US pandemic emergency stockpile, signaling that it could become the first adjuvanted flu vaccine to win approval in the United States.

Sep 27, 2012

Sep 27, 2012

USDA expands health alert for recalled Canadian beef

(CIDRAP News) – The US Department of Agriculture (USDA) yesterday expanded its warning to consumers about ground beef components imported from a Canadian company after the company's steaks were linked to eight Escherichia coli O157:H7 infections in Canada.

Pages

by Topic

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»